AngioDynamics (ANGO) vs Embecta (EMBC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AngioDynamics (ANGO) has outperformed Embecta (EMBC) over the past year, gaining 28.4% versus a loss of 57.1%. AngioDynamics is the larger company by market cap ($596.8 million vs $334.9 million), about 1.8 times the size. Embecta pays a dividend yielding 7.78%, while AngioDynamics does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | EMBC |
|---|---|---|
| Share price | $14.19 | $5.91 |
| Market cap | $596.75M | $334.86M |
| 1-day change | -1.60% | -0.67% |
| YTD return | +10.51% | -50.25% |
| 1-year return | +28.42% | -57.11% |
| 5-year return | -48.15% | — |
| P/E ratio (TTM) | — | 4.02 |
| Forward P/E | — | 3.35 |
| EPS (TTM) | $-0.88 | $1.47 |
| Dividend yield | 0.00% | 7.78% |
| Annual dividend | $0.00 | $0.46 |
| 52-week high | $16.29 | $14.91 |
| 52-week low | $9.39 | $2.77 |
| Distance from 52-week high | -12.89% | -60.36% |
| Analyst consensus | none | none |
| Avg. price target upside | +40.94% | -32.32% |
| Average volume | 506.32K | 1.38M |
| Shares outstanding | 42.05M | 56.66M |
| Employees | 632 | 1,850 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANGO has outperformed EMBC by 85.5 percentage points over the past year.
- Embecta offers a meaningfully higher dividend yield (7.78% vs 0.00%).
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Healthcare · Medical Instruments & Supplies · 632 employees
About Embecta
EMBC stock →Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Healthcare · Medical Instruments & Supplies · 1,850 employees
ANGO vs EMBC FAQ
Which is bigger, AngioDynamics or Embecta?
AngioDynamics (ANGO) is larger, with a market capitalization of $596.75M compared with $334.86M for Embecta (EMBC).
Which stock has performed better over the past year, ANGO or EMBC?
ANGO returned +28.42% over the past 12 months, compared with -57.11% for EMBC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, AngioDynamics or Embecta?
Embecta pays a dividend yielding 7.78%, while AngioDynamics does not currently pay a regular dividend.
Are AngioDynamics and Embecta in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.